发明名称 Pyrazole compounds useful as protein kinase inhibitors
摘要 Disclosed are compounds of formula III, wherein: Ring D is a 5-7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl, being optionally substituted, Rx and Ry are taken together with their intervening atoms to form a fused, unsaturated or partially unsaturated, 5-8 membered carbocyclo ring, wherein any substitutable carbon on the fused ring formed by Rx and Ry is substituted by oxo or T-R3, R2 and R2' are independently selected from -R, -T-W-R6, or R2 and R2' are taken together to form a fused 5-8 membered, unsaturated or partially unsaturated ring having 0-3 ring heteroatoms selected from nitrogen, oxygen, or sulfur, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the inhibition of GSK-3, Aurora, or Src activity.
申请公布号 NZ525009(A) 申请公布日期 2005.05.27
申请号 NZ20010525009 申请日期 2001.09.14
申请人 VERTEX PHARMACEUTICALS INCORPORATED 发明人 DAVIES, ROBERT;BEBBINGTON, DAVID;BINCH, HALEY;KNEGTEL, RONALD;GOLEC, JULIAN M C;PATEL, SANJAY;CHARRIER, JEAN-DAMIEN;KAY, DAVID;DAVIES, ROBERT
分类号 C07D403/12;A61K31/415;A61K31/437;A61K31/4709;A61K31/4725;A61K31/501;A61K31/5025;A61K31/506;A61K31/517;A61K31/519;A61K31/52;A61K31/53;A61K31/5377;A61K31/541;A61K31/55;A61K45/00;A61P1/16;A61P3/08;A61P3/10;A61P3/14;A61P5/00;A61P9/00;A61P9/10;A61P11/06;A61P17/06;A61P19/00;A61P19/02;A61P19/10;A61P25/18;A61P25/28;A61P29/00;A61P31/12;A61P35/00;A61P35/02;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D239/26;C07D239/36;C07D239/70;C07D239/88;C07D401/12;C07D401/14;C07D403/14;C07D405/14;C07D407/14;C07D409/14;C07D413/14;C07D417/14;C07D471/04;C07D473/16;C07D475/10;C07D487/04;C07D491/04;C07D491/044;C07D491/048;C07D491/052;C07D491/107;C07D491/113;C07D491/20;C07D493/04;C07D495/04;C07D498/04;C07D513/04;C07D521/00;(IPC1-7):C07D403/12 主分类号 C07D403/12
代理机构 代理人
主权项
地址